Cargando…

The circular RNA hsa_circ_0001394 promotes hepatocellular carcinoma progression by targeting the miR-527/UBE2A axis

Circular RNAs (circRNAs) have been recognized as significant participants in the progression of different cancers; however, the detailed mechanisms of circRNAs in hepatocellular carcinoma (HCC) remain unclear. In this study, hsa_circ_0001394 was identified by RNA-seq analysis, and hsa_circ_0001394 w...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Yu, Nie, Yu, Peng, Chun, Xing, Fuchen, Ji, Saiguang, Liu, Hong, Zhu, Chuandong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8873434/
https://www.ncbi.nlm.nih.gov/pubmed/35210429
http://dx.doi.org/10.1038/s41420-022-00866-0
_version_ 1784657466851590144
author Yan, Yu
Nie, Yu
Peng, Chun
Xing, Fuchen
Ji, Saiguang
Liu, Hong
Zhu, Chuandong
author_facet Yan, Yu
Nie, Yu
Peng, Chun
Xing, Fuchen
Ji, Saiguang
Liu, Hong
Zhu, Chuandong
author_sort Yan, Yu
collection PubMed
description Circular RNAs (circRNAs) have been recognized as significant participants in the progression of different cancers; however, the detailed mechanisms of circRNAs in hepatocellular carcinoma (HCC) remain unclear. In this study, hsa_circ_0001394 was identified by RNA-seq analysis, and hsa_circ_0001394 was determined to be highly expressed in HCC specimens and cell lines. Patients with high expression of hsa_circ_0001394 tended to exhibit poor survival. Increased hsa_circ_0001394 expression in plasma was closely correlated with clinicopathological features including elevated vascular invasion and an advanced TNM stage, as indicated by alpha-fetoprotein (AFP) analysis. Hsa_circ_0001394 promoted the proliferation, migration, and invasion of HCC cells, whereas knockdown of hsa_circ_0001394 inhibited HCC tumorigenesis in vivo. In addition, mechanistic studies showed that miR-527 negatively interacted with hsa_circ_0001394. Furthermore, UBE2A was revealed to serve as a target of miR-527. Overall, the present study suggested that hsa_circ_0001394 may function as a sponge to promote HCC progression by regulating the miR-527/UBE2A pathway. Thus, hsa_circ_0001394 may become a promising biomarker and potential therapeutic target in HCC treatment.
format Online
Article
Text
id pubmed-8873434
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-88734342022-03-17 The circular RNA hsa_circ_0001394 promotes hepatocellular carcinoma progression by targeting the miR-527/UBE2A axis Yan, Yu Nie, Yu Peng, Chun Xing, Fuchen Ji, Saiguang Liu, Hong Zhu, Chuandong Cell Death Discov Article Circular RNAs (circRNAs) have been recognized as significant participants in the progression of different cancers; however, the detailed mechanisms of circRNAs in hepatocellular carcinoma (HCC) remain unclear. In this study, hsa_circ_0001394 was identified by RNA-seq analysis, and hsa_circ_0001394 was determined to be highly expressed in HCC specimens and cell lines. Patients with high expression of hsa_circ_0001394 tended to exhibit poor survival. Increased hsa_circ_0001394 expression in plasma was closely correlated with clinicopathological features including elevated vascular invasion and an advanced TNM stage, as indicated by alpha-fetoprotein (AFP) analysis. Hsa_circ_0001394 promoted the proliferation, migration, and invasion of HCC cells, whereas knockdown of hsa_circ_0001394 inhibited HCC tumorigenesis in vivo. In addition, mechanistic studies showed that miR-527 negatively interacted with hsa_circ_0001394. Furthermore, UBE2A was revealed to serve as a target of miR-527. Overall, the present study suggested that hsa_circ_0001394 may function as a sponge to promote HCC progression by regulating the miR-527/UBE2A pathway. Thus, hsa_circ_0001394 may become a promising biomarker and potential therapeutic target in HCC treatment. Nature Publishing Group UK 2022-02-24 /pmc/articles/PMC8873434/ /pubmed/35210429 http://dx.doi.org/10.1038/s41420-022-00866-0 Text en © The Author(s) 2022, corrected publication 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Yan, Yu
Nie, Yu
Peng, Chun
Xing, Fuchen
Ji, Saiguang
Liu, Hong
Zhu, Chuandong
The circular RNA hsa_circ_0001394 promotes hepatocellular carcinoma progression by targeting the miR-527/UBE2A axis
title The circular RNA hsa_circ_0001394 promotes hepatocellular carcinoma progression by targeting the miR-527/UBE2A axis
title_full The circular RNA hsa_circ_0001394 promotes hepatocellular carcinoma progression by targeting the miR-527/UBE2A axis
title_fullStr The circular RNA hsa_circ_0001394 promotes hepatocellular carcinoma progression by targeting the miR-527/UBE2A axis
title_full_unstemmed The circular RNA hsa_circ_0001394 promotes hepatocellular carcinoma progression by targeting the miR-527/UBE2A axis
title_short The circular RNA hsa_circ_0001394 promotes hepatocellular carcinoma progression by targeting the miR-527/UBE2A axis
title_sort circular rna hsa_circ_0001394 promotes hepatocellular carcinoma progression by targeting the mir-527/ube2a axis
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8873434/
https://www.ncbi.nlm.nih.gov/pubmed/35210429
http://dx.doi.org/10.1038/s41420-022-00866-0
work_keys_str_mv AT yanyu thecircularrnahsacirc0001394promoteshepatocellularcarcinomaprogressionbytargetingthemir527ube2aaxis
AT nieyu thecircularrnahsacirc0001394promoteshepatocellularcarcinomaprogressionbytargetingthemir527ube2aaxis
AT pengchun thecircularrnahsacirc0001394promoteshepatocellularcarcinomaprogressionbytargetingthemir527ube2aaxis
AT xingfuchen thecircularrnahsacirc0001394promoteshepatocellularcarcinomaprogressionbytargetingthemir527ube2aaxis
AT jisaiguang thecircularrnahsacirc0001394promoteshepatocellularcarcinomaprogressionbytargetingthemir527ube2aaxis
AT liuhong thecircularrnahsacirc0001394promoteshepatocellularcarcinomaprogressionbytargetingthemir527ube2aaxis
AT zhuchuandong thecircularrnahsacirc0001394promoteshepatocellularcarcinomaprogressionbytargetingthemir527ube2aaxis
AT yanyu circularrnahsacirc0001394promoteshepatocellularcarcinomaprogressionbytargetingthemir527ube2aaxis
AT nieyu circularrnahsacirc0001394promoteshepatocellularcarcinomaprogressionbytargetingthemir527ube2aaxis
AT pengchun circularrnahsacirc0001394promoteshepatocellularcarcinomaprogressionbytargetingthemir527ube2aaxis
AT xingfuchen circularrnahsacirc0001394promoteshepatocellularcarcinomaprogressionbytargetingthemir527ube2aaxis
AT jisaiguang circularrnahsacirc0001394promoteshepatocellularcarcinomaprogressionbytargetingthemir527ube2aaxis
AT liuhong circularrnahsacirc0001394promoteshepatocellularcarcinomaprogressionbytargetingthemir527ube2aaxis
AT zhuchuandong circularrnahsacirc0001394promoteshepatocellularcarcinomaprogressionbytargetingthemir527ube2aaxis